Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To evaluate the efficacy of crenezumab compared with placebo based on change from baseline to Week (W) 105 in global outcomes as assessed by Clinical Dementia Rating-Sum of Boxes (CDR-SB) Evaluar la eficacia de crenezumab en comparación con placebo determinados mediante la CDR-SB, entre el momento basal y la semana 105.
Critère d'inclusion
- Alzheimer's disease,Enfermedad de Alzheimer